Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)
Mimedx recorded quarterly Liabilities from Discontinued Operations of 217000.0 in Q2 2024, down 36.92% quarter-over-quarter from 344000.0 in Q1 2024.
Mimedx's Liabilities from Discontinued Operations history runs 3 years deep, the most recent figure standing at 217000.0 for Q2 2024.
- In Q2 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 217000.0; the TTM figure through Jun 2024 stood at 217000.0 (changed N/A YoY), while the FY2023 annual figure was 1352000.0, down 8.59% from the prior year.
- Liabilities from Discontinued Operations came in at 217000.0 for Q2 2024 at Mimedx, down from 344000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 1479000.0 in Q4 2022 to a low of 217000.0 in Q2 2024.
- A 3-year average of 848000.0 and a median of 848000.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
- On a YoY basis, Liabilities from Discontinued Operations climbed as much as 8.59% in 2023 and fell as far as 8.59% in 2023.
- Mimedx's Liabilities from Discontinued Operations stood at 1479000.0 in 2022, then decreased by 8.59% to 1352000.0 in 2023, then sank by 83.95% to 217000.0 in 2024.
- According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 217000.0, 344000.0, and 1352000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 217,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Dec 31, 2022 | 1.48 Mn |